Hedeker Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Hedeker Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$472.8 - $558.54 $2.3 Million - $2.72 Million	-4,862 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$446.73 - $548.2 $11,168 - $13,705	25 Added 0.52%	4,862 $2.3 Million
Q4 2020 Jan 19, 2021	BUY	$478.3 - $607.98 $237,715 - $302,166	497 Added 11.45%	4,837 $2.34 Million
Q3 2020 Oct 26, 2020	BUY	$544.75 - $658.21 $1.8 Million - $2.18 Million	3,306 Added 319.73%	4,340 $2.43 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $510,092 - $665,813	1,034 New	1,034 $644,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hedeker Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Hedeker Wealth, LLC with notifications on news.